NEW YORK LIFE INVESTMENT MANAGEMENT LLCNEW YORK LIFE INVESTMENT MANAGEMENT LLC

Institutional investor · Portfolio as of Q1 2022

SEC EDGAR SourceSEC Filings

Top Holdings52 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
IQSUIQSU
ETF

NEW YORK LIFE INVESTMENTS ET

10.7M$419.9M22.2%$29.06+29.85%
8 qtrssince 2020-Q2
Decreased
0
CLRGCLRGDelisted
ETF

IQ U.S. Large Cap ETF

9.3M$324.9M17.2%$21.96+56.52%
13 qtrssince 2019-Q1
Increased
60
IQINIQINDelisted
ETF

NYLI 500 International ETF

6.8M$214.2M11.3%$19.46+48.03%
13 qtrssince 2019-Q1
Decreased
0
IQSIIQSI
ETF

NEW YORK LIFE INVESTMENTS ET

7.2M$199.3M10.5%$22.05+13.61%
8 qtrssince 2020-Q2
Increased
63
CSMLCSMLDelisted
ETF

IQ U.S. Small Cap ETF

4.6M$160.8M8.5%$25.01+37.14%
13 qtrssince 2019-Q1
Decreased
0
HFXIHFXI
ETF

NYLI FTSE INTERNATIONAL EQUITY CURRENCY NEUTRAL ETF

6.3M$147.9M7.8%$15.68+32.49%
13 qtrssince 2019-Q1
Decreased
0
CPLBCPLB
ETF

NEW YORK LIFE INVTS ACTIVE E

2.6M$61.7M3.3%$19.300.00%
1 qtr
New
82
MGCMGC
ETF

VANGUARD MEGA CAP ETF

307,832$49M2.6%$127.59+20.40%
8 qtrssince 2020-Q2
Increased
54
IEFAIEFA
ETF

ISHARES CORE MSCI EAFE ETF

495,552$34.4M1.8%$59.90+3.74%
8 qtrssince 2020-Q2
Increased
48
IWDIWD
ETF

ISHARES TR RUSSELL 1000 VALUE INDEX FUND

161,743$26.8M1.4%$137.67+13.47%
10 qtrssince 2019-Q4
Increased
66
MMCAMMCA
ETF

NEW YORK LIFE INVTS ACTIVE E

980,000$22.5M1.2%$21.79-8.08%
2 qtrssince 2021-Q4
Unchanged
0
SCHASCHA
ETF

SCHWAB US SMALL-CAP ETF

395,304$18.7M1.0%$23.39-2.92%
5 qtrssince 2021-Q1
Increased
58
GVIGVI
ETF

ISHARES TR

168,354$18.3M1.0%$100.94-5.66%
13 qtrssince 2019-Q1
Decreased
0
SHVSHV
ETF

ISHARES SHORT TREASURY BOND

157,474$17.4M0.9%$90.67+2.28%
13 qtrssince 2019-Q1
Unchanged
0
VOVO
ETF

VANGUARD MID-CAP ETF

71,524$17M0.9%$48.94+13.60%
8 qtrssince 2020-Q2
Increased
40
BKLNBKLN
ETF

INVESCO EXCH TRADED FD TR II

694,257$15.1M0.8%$15.47+2.48%
13 qtrssince 2019-Q1
Increased
41
SCHZSCHZ
ETF

SCHWAB US AGGREGATE BOND ETF

287,660$14.5M0.8%$23.63-6.85%
8 qtrssince 2020-Q2
Decreased
0
AGGAGG
ETF

ISHARES TR

135,664$14.5M0.8%$98.77-6.78%
8 qtrssince 2020-Q2
Decreased
0
IJRIJR
ETF

ISHARES CORE S&P SMALL-CAP ETF ETF

117,770$12.7M0.7%$102.30+0.13%
5 qtrssince 2021-Q1
Increased
64
MGVMGV
ETF

VANGUARD WORLD FD

109,498$11.8M0.6%$81.56+21.87%
8 qtrssince 2020-Q2
Increased
40
$1.9B
AUM
52
Positions
Q1 2022
Filing
Rating · 4.0
Quarterly Portfolio Change
+35%Q4'20$1.5B+11%Q1'21$1.7B+4%Q2'21$1.7B+5%Q3'21$1.8B+6%Q4'21$1.9B-1%Q1'22$1.9B
Activity profile
$ moved · Q1'22
New32%Increased23%Decreased43%Exited2%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.3 years
<1Q13%1-4Q31%1-2Y31%2Y+25%

NEW YORK LIFE INVESTMENT MANAGEMENT LLC manages $1.9B across 52 positions as of Q1 2022. Top holdings: IQSU (22.2%), CLRG (17.2%), IQIN (11.3%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 4/5.0.

Q1 2022 Summary

Active quarter - 7 new positions, 1 exits, 24 increased. Top move: CPLB (NEW, conviction 82). Portfolio: $1.9B across 52 positions.

Top holdings by portfolio weight

Total AUM$2B
IQSU22.17%
CLRG17.16%
IQIN11.31%
IQSI10.52%
CSML8.49%
HFXI7.81%
CPLB3.26%
MGC2.59%
IEFA1.82%
IWD1.42%
Other1.19%

Portfolio allocation by GICS sector

Sectors1
Unknown100.00%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown
Compare DNA across all funds
7-dimension quality assessment
Strong(4.0 / 5.0)
Track Record70
Conviction40
Concentration43
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
USHYUSHYISHARES BROAD USD HIGH YIELD
Q3 2024 Q2 2026+906,416 shares+$33.7M
7Q
APHAPHAMPHENOL CORP-CL A
Q4 2024 Q2 2026+10,995 shares+$19.8M
7Q
ATOATOATMOS ENERGY CORP
Q4 2024 Q2 2026+2,574 shares+$1.1M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used